Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B
Carcinogenesis, 03/12/09
Asaka SI et al. - The results indicated that the LOH of APC and p53 mutation has already occurred by the Dukes’ A lake ‘suppressor pathway’ but not the KRAS mutation in MSI-L CRCs. The genes involving MSI-L carcinogenesis are similar to MSS but the timing and frequency of the KRAS mutation is different.
Related Articles
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma
The Journal of Pathology, 10/16/09
Relevance Score: 73%%
Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/05/09
Relevance Score: 70%%
Cetuximab-based treatment of metastatic anal cancer: Correlation of response with KRAS mutational status
Oncology (Karger), 11/18/09
Relevance Score: 69%%
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Journal of Clinical Oncology, 11/12/09
Relevance Score: 68%%
KRAS mutation, KRAS–LCS6 polymorphism, and non-small cell lung cancer
Lung Cancer, 10/29/09
Relevance Score: 68%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/29/09
Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer
Journal of Clinical Oncology, 11/29/09
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/29/09
Today in Carcinogenesis...keeping you current
Receive free subspecialty "5-minute updates" via email
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/25/09
Association of rare MSH6 variants with familial breast cancer
Breast Cancer Research and Treatment, 11/25/09
APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


